日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Adipose-enriched peri-tumoral stroma, in contrast to myofibroblast-enriched stroma, prognosticates poorer survival in breast cancers

与富含肌成纤维细胞的肿瘤周围基质相比，富含脂肪组织的肿瘤周围基质预示着乳腺癌患者生存率较差。

期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-023-00590-7
Lau, Hannah Si Hui; Tan, Veronique Kiak Mien; Tan, Benita Kiat Tee; Sim, Yirong; Quist, Jelmar; Thike, Aye Aye; Tan, Puay Hoon; Pervaiz, Shazib; Grigoriadis, Anita; Sabapathy, Kanaga
成纤维细胞
肿瘤
肿瘤免疫
乳腺癌
细胞生物学
发表日期：2023
文献求助 收藏

Predicting Breast Cancer Events in Ductal Carcinoma In Situ (DCIS) Using Generative Adversarial Network Augmented Deep Learning Model

利用生成对抗网络增强深度学习模型预测导管原位癌（DCIS）中的乳腺癌事件

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers15071922
Ghose, Soumya; Cho, Sanghee; Ginty, Fiona; McDonough, Elizabeth; Davis, Cynthia; Zhang, Zhanpan; Mitra, Jhimli; Harris, Adrian L; Thike, Aye Aye; Tan, Puay Hoon; Gökmen-Polar, Yesim; Badve, Sunil S
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

The scaffold RhoGAP protein ARHGAP8/BPGAP1 synchronizes Rac and Rho signaling to facilitate cell migration.

支架蛋白 RhoGAP 蛋白 ARHGAP8/BPGAP1 可同步 Rac 和 Rho 信号传导，从而促进细胞迁移

期刊:Molecular Biology of the Cell
影响因子:2.7
doi:10.1091/mbc.E21-03-0099
Wong Darren Chen Pei, Pan Catherine Qiurong, Er Shi Yin, Thivakar T, Rachel Tan Zi Yi, Seah Sock Hong, Chua Pei Jou, Jiang Tingting, Chew Ti Weng, Chaudhuri Parthiv Kant, Mukherjee Somsubhro, Salim Agus, Aye Thike Aye, Koh Cheng Gee, Lim Chwee Teck, Tan Puay Hoon, Bay Boon Huat, Ridley Anne J, Low Boon Chuan
细胞生物学
发表日期：2023
文献求助 收藏

More microinvasive foci in larger tumours of breast ductal carcinoma in situ

乳腺导管原位癌较大肿瘤中微浸润灶较多。

期刊:
影响因子:
doi:10.11622/smedj.2022089
Chen, Xiao-Yang; Thike, Aye Aye; Lim, Johnathan Xiande; Bay, Boon Huat; Tan, Puay Hoon
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Therapeutic and immunomodulatory potential of pazopanib in malignant phyllodes tumor

帕唑帕尼对恶性叶状肿瘤的治疗和免疫调节潜力

期刊:NPJ Breast Cancer
影响因子:6.5
doi:10.1038/s41523-022-00413-1
Dave Yong Xiang Ng #, Zhimei Li #, Elizabeth Lee, Jessica Sook Ting Kok, Jing Yi Lee, Joanna Koh, Cedric Chuan-Young Ng, Abner Herbert Lim, Wei Liu, Sheng Rong Ng, Kah Suan Lim, Xi Xiao Huang, Jing Han Hong, Peiyong Guan, Yirong Sim, Aye Aye Thike, Nur Diyana Md Nasir, Shang Li, Puay Hoon Tan, Bin T
肿瘤
FCM
Mouse
PTPRC
发表日期：2022
文献求助 收藏

Hypoxia-regulated carbonic anhydrase IX (CAIX) protein is an independent prognostic indicator in triple negative breast cancer

缺氧调节碳酸酐酶IX (CAIX) 蛋白是三阴性乳腺癌的独立预后指标

期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-022-01532-0
Ong, Chong Hui Clara; Lee, Dong Yeul; Lee, Bernett; Li, Huihua; Lim, Jeffrey Chun Tatt; Lim, Johnathan Xiande; Yeong, Joe Poh Sheng; Lau, Hiu Yeung; Thike, Aye Aye; Tan, Puay Hoon; Iqbal, Jabed
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast

乳腺导管原位癌 (DCIS) 多国队列研究中的肿瘤浸润淋巴细胞

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers14163916
Badve, Sunil S; Cho, Sanghee; Lu, Xiaoyu; Cao, Sha; Ghose, Soumya; Thike, Aye Aye; Tan, Puay Hoon; Ocal, Idris Tolgay; Generali, Daniele; Zanconati, Fabrizio; Harris, Adrian L; Ginty, Fiona; Gökmen-Polar, Yesim
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

A comprehensive next generation sequencing tissue assay for Asian-prevalent cancers-Analytical validation and performance evaluation with clinical samples

针对亚洲流行癌症的全面下一代测序组织检测——使用临床样本进行分析验证和性能评估

期刊:Frontiers in Molecular Biosciences
影响因子:3.9
doi:10.3389/fmolb.2022.963243
Cedric Chuan-Young Ng, Sandy Lim, Abner Herbert Lim, Nur Diyana Md Nasir, Jingxian Zhang, Vikneswari Rajasegaran, Jing Yi Lee, Jessica Sook Ting Kok, Aye Aye Thike, Johnathan Xiande Lim, Ruifen Weng, Sidney Yee, Yukti Choudhury, Jason Yongsheng Chan, Puay Hoon Tan, Min-Han Tan, Bin Tean Teh
肿瘤
发表日期：2022
文献求助 收藏

Medullary breast carcinoma: a pathogenic review and immunohistochemical study using tissue microarray

髓样乳腺癌：基于组织芯片的病理学综述和免疫组织化学研究

期刊:
影响因子:
doi:10.11622/smedj.2021031
Lee, Ming; Jara-Lazaro, Ana Richelia; Cheok, Poh Yian; Thike, Aye Aye
肿瘤
IHC
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2022
文献求助 收藏

Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancers

表观遗传去抑制将 PPARγ 转化为三阴性乳腺癌和内分泌耐药乳腺癌的可用药靶点

期刊:Cell Death Discovery
影响因子:6.1
doi:10.1038/s41420-021-00635-5
Ser Yue Loo #, Nicholas L Syn #, Angele Pei-Fern Koh, Janet Cheng-Fei Teng, Amudha Deivasigamani, Tuan Zea Tan, Aye Aye Thike, Shireen Vali, Shweta Kapoor, Xiaoyuan Wang, Jiong Wei Wang, Puay Hoon Tan, George W Yip, Gautam Sethi, Ruby Yun-Ju Huang, Kam Man Hui, Lingzhi Wang, Boon Cher Goh, Alan Prem
肿瘤
乳腺癌
发表日期：2021
文献求助 收藏